Approach to Statin Use in 2016: an Update

P. Elliott Miller, Seth Martin

Research output: Contribution to journalArticle

Abstract

Statin therapy is the pharmacologic foundation of cholesterol treatment and the most common class of medication prescribed in the USA. The clinical benefits of statins and their favorable side effect profile have been well established for atherosclerotic cardiovascular disease prevention. With new guidelines on the treatment of dyslipidemia being published in the last several years, a greater percentage of the population now appears eligible for statin therapy. In this review, we discuss the updated American College of Cardiology/American Heart Association and National Lipid Association guidelines on lipid treatment, both of which endorse the importance of shared decision making and patient-centered care. We discuss factors beyond traditional risk factors that may be useful in refining risk-based decision making. Furthermore, we summarize the available statins, their potential benefits and limitations, and recent evidence on safety and tolerability.

Original languageEnglish (US)
Article number20
JournalCurrent Atherosclerosis Reports
Volume18
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Decision Making
Guidelines
Lipids
Patient-Centered Care
Dyslipidemias
Cardiovascular Diseases
Cholesterol
Safety
Therapeutics
Population

Keywords

  • Cardiovascular imaging
  • Guidelines
  • Hyperlipidemia
  • Statins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Approach to Statin Use in 2016 : an Update. / Miller, P. Elliott; Martin, Seth.

In: Current Atherosclerosis Reports, Vol. 18, No. 5, 20, 01.05.2016.

Research output: Contribution to journalArticle

@article{306ef6ab263c4e7eb25daa224b72934e,
title = "Approach to Statin Use in 2016: an Update",
abstract = "Statin therapy is the pharmacologic foundation of cholesterol treatment and the most common class of medication prescribed in the USA. The clinical benefits of statins and their favorable side effect profile have been well established for atherosclerotic cardiovascular disease prevention. With new guidelines on the treatment of dyslipidemia being published in the last several years, a greater percentage of the population now appears eligible for statin therapy. In this review, we discuss the updated American College of Cardiology/American Heart Association and National Lipid Association guidelines on lipid treatment, both of which endorse the importance of shared decision making and patient-centered care. We discuss factors beyond traditional risk factors that may be useful in refining risk-based decision making. Furthermore, we summarize the available statins, their potential benefits and limitations, and recent evidence on safety and tolerability.",
keywords = "Cardiovascular imaging, Guidelines, Hyperlipidemia, Statins",
author = "Miller, {P. Elliott} and Seth Martin",
year = "2016",
month = "5",
day = "1",
doi = "10.1007/s11883-016-0578-1",
language = "English (US)",
volume = "18",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "5",

}

TY - JOUR

T1 - Approach to Statin Use in 2016

T2 - an Update

AU - Miller, P. Elliott

AU - Martin, Seth

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Statin therapy is the pharmacologic foundation of cholesterol treatment and the most common class of medication prescribed in the USA. The clinical benefits of statins and their favorable side effect profile have been well established for atherosclerotic cardiovascular disease prevention. With new guidelines on the treatment of dyslipidemia being published in the last several years, a greater percentage of the population now appears eligible for statin therapy. In this review, we discuss the updated American College of Cardiology/American Heart Association and National Lipid Association guidelines on lipid treatment, both of which endorse the importance of shared decision making and patient-centered care. We discuss factors beyond traditional risk factors that may be useful in refining risk-based decision making. Furthermore, we summarize the available statins, their potential benefits and limitations, and recent evidence on safety and tolerability.

AB - Statin therapy is the pharmacologic foundation of cholesterol treatment and the most common class of medication prescribed in the USA. The clinical benefits of statins and their favorable side effect profile have been well established for atherosclerotic cardiovascular disease prevention. With new guidelines on the treatment of dyslipidemia being published in the last several years, a greater percentage of the population now appears eligible for statin therapy. In this review, we discuss the updated American College of Cardiology/American Heart Association and National Lipid Association guidelines on lipid treatment, both of which endorse the importance of shared decision making and patient-centered care. We discuss factors beyond traditional risk factors that may be useful in refining risk-based decision making. Furthermore, we summarize the available statins, their potential benefits and limitations, and recent evidence on safety and tolerability.

KW - Cardiovascular imaging

KW - Guidelines

KW - Hyperlipidemia

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=84960960665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960960665&partnerID=8YFLogxK

U2 - 10.1007/s11883-016-0578-1

DO - 10.1007/s11883-016-0578-1

M3 - Article

C2 - 26973129

AN - SCOPUS:84960960665

VL - 18

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 5

M1 - 20

ER -